Shereen Medhat Mohammed Elsayed Nassar
1 clinical trials · Sponsor
◉ Watch Shereen Medhat Mohammed Elsayed Nassar
| Record | Firm | Date |
|---|---|---|
| Rituximab Therapy in Patients With Treatment Refractory Hypersenstivity Pneumonitis (NCT07035561) | Shereen Medhat Mohammed Elsayed Nassar | 2023-06-01 |
Track Shereen Medhat Mohammed Elsayed Nassar automatically
Every clearance here is in the API, with alerts when new ones post.